Enhabit Home Health & Hospice Bundle
What is the history of Enhabit Home Health & Hospice?
Enhabit Home Health & Hospice is a key player in in-home healthcare, offering personalized care nationwide. It became an independent, publicly traded company on July 1, 2022, after spinning off from Encompass Health Corporation.
The company's origins trace back to Encompass Home Health, Inc., established in Dallas, Texas, in 1998, giving it a substantial foundation in the home health and hospice sectors.
What is the brief history of Enhabit Home Health & Hospice?
The company's journey began in 1998 as Encompass Home Health, Inc. in Dallas, Texas. A significant milestone was its official spin-off from Encompass Health Corporation on July 1, 2022, leading to its establishment as an independent, publicly traded entity under the ticker EHAB. This strategic move aimed to provide greater flexibility in operations and strategy, focusing on patient, employee, and investor interests. The company's vision centers on delivering high-quality, cost-effective care within patients' homes, addressing the increasing demand for such services. As of the second quarter of 2025, Enhabit operates approximately 251 home health locations and 113 hospice locations across 34 states, positioning it as the fourth-largest home health provider and a leading hospice provider in the U.S. For a deeper understanding of its market context, consider an Enhabit Home Health & Hospice PESTEL Analysis.
What is the Enhabit Home Health & Hospice Founding Story?
Enhabit Home Health & Hospice officially began its journey as a standalone, publicly traded entity on July 1, 2022, following its separation from Encompass Health Corporation. This strategic move was a result of a comprehensive review initiated in 2020, influenced by various factors including investor input and industry pressures.
Enhabit Home Health & Hospice emerged as an independent company in 2022, but its roots trace back to 1998 with the establishment of Encompass Home Health in Dallas, Texas. The company's evolution reflects a strategic decision to focus on in-home care services.
- The spin-off from Encompass Health Corporation occurred on July 1, 2022.
- The origins of Enhabit's operations date back to Encompass Home Health, founded in 1998.
- Barb Jacobsmeyer, with extensive experience in the sector, leads Enhabit as President and CEO.
- The name 'Enhabit' signifies comfort and well-being, with 'en' referencing its Encompass Health legacy.
The strategic review by Encompass Health in 2020, spurred by activist investor pressure and challenges like the COVID-19 pandemic and Medicare sequestration, led to the decision to spin off its home health and hospice division. This separation was designed to grant Enhabit greater strategic and operational autonomy, allowing for a more concentrated focus on its specialized in-home care services. While Enhabit Inc. commenced operations in 2022, its operational history is deeply intertwined with Encompass Home Health, Inc., which was founded in Dallas, Texas, in 1998. This predecessor entity steadily expanded its reach across Texas, Oklahoma, and New Mexico, building a foundation for the services Enhabit offers today. Barb Jacobsmeyer, who has been at the helm as President and CEO since June 2021, was instrumental in guiding the company through this significant transition. Her prior role as Executive Vice President of Operations at Encompass Health provided her with substantial expertise in the home health and hospice landscape. The company's foundational business model was built around delivering a comprehensive suite of in-home healthcare solutions, encompassing skilled nursing, various therapies (physical, occupational, and speech), medical social services, and end-of-life hospice care. The selection of the name 'Enhabit' was deliberate, aiming to evoke a sense of comfort and belonging associated with residing in one's home, while the 'en' prefix served as a direct acknowledgment of its lineage with Encompass Health. As a spin-off, Enhabit did not follow a traditional funding path; instead, its shares were distributed directly to Encompass Health stockholders, marking its debut as a distinct, publicly traded company. This establishment as a standalone entity coincided with a growing societal appreciation for healthcare solutions that are both cost-effective and preferred by patients for their delivery within the home environment. Understanding the Competitors Landscape of Enhabit Home Health & Hospice provides further context to its market positioning.
Enhabit Home Health & Hospice SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
What Drove the Early Growth of Enhabit Home Health & Hospice?
Following its spin-off on July 1, 2022, Enhabit Home Health & Hospice initiated a growth strategy encompassing organic expansion and strategic acquisitions. The company's early trajectory included strengthening its hospice segment, a key driver of its development.
Enhabit's early growth phase saw the acquisition of Caring Hearts Hospice in October 2022, adding four locations in Texas. This move bolstered the company's hospice services, a focus area for its expansion efforts.
Under President and CEO Barb Jacobsmeyer, Enhabit pursued de novo development, aiming for approximately 10 new locations annually, with a 60/40 split favoring hospice services. In 2024, five new hospice operations were established, building on previous years' openings.
By Q2 2025, Enhabit operated 251 home health locations and 113 hospice locations across 34 states. The company's operations were supported by a workforce exceeding 10,000 employees.
Enhabit made a significant strategic decision in August 2024 to terminate its contract with UnitedHealthcare, later establishing a new home health agreement in December 2024. The company also focused on cost savings, renegotiating 43 payer contracts in Q1 2025 and transitioning to outsourced coding, projected to save $1.5 million for the remainder of 2025. These actions reflect the Revenue Streams & Business Model of Enhabit Home Health & Hospice.
Enhabit Home Health & Hospice PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
What are the key Milestones in Enhabit Home Health & Hospice history?
The Enhabit Home Health & Hospice company has experienced significant growth and transformation since its inception. A pivotal moment was its spin-off and establishment as an independent, publicly traded entity on July 1, 2022. This strategic move aimed to foster greater flexibility within the home-based care sector. The company has also been recognized for its positive work environment, earning a spot on U.S. News & World Report's 2024-2025 Best Companies to Work For list. Further underscoring its dedication to quality care, Enhabit was acknowledged by the Institute for Healthcare Improvement (IHI) as an Age-Friendly Health Systems Participant in October 2024.
| Year | Milestone |
|---|---|
| 2022 | Became an independent, publicly traded company on July 1st. |
| 2024 | Named one of U.S. News & World Report's Best Companies to Work For. |
| 2024 | Recognized by the Institute for Healthcare Improvement (IHI) as an Age-Friendly Health Systems Participant. |
Enhabit is actively integrating advanced technologies to enhance patient care and operational efficiency. The company is implementing AI to reduce documentation burdens and streamline administrative tasks like scheduling and patient communication, thereby freeing up clinical staff for direct patient interaction. This technological focus is projected to yield approximately $1.5 million in cost savings for 2025 through initiatives such as outsourced coding.
Leveraging AI to minimize documentation redundancies and optimize back-office operations like scheduling and patient communication.
Piloting a VPE management program to reduce visits per patient episode by an estimated 0.5, aiming for annual savings of $5-8 million.
Implemented a new case management model in 2023 that has positively impacted hospice clinical workforce retention and contributed to census growth.
The company has encountered significant challenges, particularly within its home health segment, due to regulatory changes. These include the 2025 CMS final rule's permanent -1.975% payment adjustment, which follows two prior years of Medicare rate reductions, and a proposed 6.4% cut in the 2026 rule. The transition to OASIS-E and the introduction of new social determinants of health (SDoH) data collection have also put pressure on margins and increased administrative duties for clinical staff. In 2024, Enhabit reported a net loss of $46.0 million, and its home health revenue saw a 5.9% decrease in Q1 2025 compared to the previous year. The company also navigated a contract termination with UnitedHealthcare in August 2024, though a new agreement was reached by December 2024. To address these issues, Enhabit has focused on cost controls, debt reduction, including prepaying $50 million in debt since Q1 2024, and renegotiating payer contracts. The hospice segment has demonstrated resilience, with average daily census increasing by 12.3% year-over-year in Q1 2025 and revenue growing by 20.5%, providing a stable, high-margin foundation.
Facing consecutive Medicare rate reductions, including a -1.975% adjustment in the 2025 CMS final rule and a proposed 6.4% cut for 2026.
The transition to OASIS-E and new SDoH data collection have increased administrative tasks for clinical staff and impacted margins.
Reported a net loss of $46.0 million in 2024 and a 5.9% decline in home health revenue in Q1 2025, necessitating cost control and debt reduction efforts.
Navigated a contract termination with a major payer in August 2024, highlighting the importance of strategic payer relationships.
Actively reducing debt, having prepaid $50 million since Q1 2024, to improve financial leverage and reduce the net debt-to-EBITDA ratio.
The hospice division shows robust growth with a 12.3% increase in average daily census and a 20.5% revenue rise in Q1 2025, acting as a key financial anchor.
Enhabit Home Health & Hospice Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What is the Timeline of Key Events for Enhabit Home Health & Hospice?
The journey of Enhabit Home Health & Hospice, from its origins to its current standing, is a narrative of strategic evolution and growth within the home-based care sector. Understanding the Enhabit company background reveals a commitment to patient care and operational expansion.
| Year | Key Event |
|---|---|
| 1998 | Encompass Home Health, Inc. was established in Dallas, Texas, marking the initial steps in what would become Enhabit. |
| 2014 | HealthSouth, later known as Encompass Health, acquired Encompass Home Health, integrating it into a larger healthcare system. |
| 2018 | HealthSouth rebranded to Encompass Health, and its home health and hospice division was recognized as Encompass Health Home Health & Hospice. |
| June 2021 | Barb Jacobsmeyer was appointed President and CEO of the home health and hospice business, leading up to its independent status. |
| January 2022 | Encompass Health announced its plan to spin off its home health and hospice operations into a new, independent company. |
| July 1, 2022 | Enhabit Home Health & Hospice completed its spin-off from Encompass Health and began trading on the NYSE under the ticker EHAB, signifying its debut as a standalone entity. |
| October 1, 2022 | Enhabit expanded its hospice services by acquiring Caring Hearts Hospice, adding four new locations in Texas. |
| 2023 | A new case management model was implemented to enhance hospice workforce retention and foster census growth. |
| August 2024 | Enhabit terminated its contract with UnitedHealthcare's UnitedHealthcare. |
| October 2024 | The Institute for Healthcare Improvement recognized Enhabit as an Age-Friendly Health Systems Participant. |
| December 2024 | Enhabit reached a new home health agreement with UnitedHealthcare, restoring a key payer relationship. |
| Q1 2025 | The company renegotiated 43 payer contracts, implemented cost-saving measures including branch consolidation, and saw its hospice average daily census grow by 12.3% year-over-year. |
| August 2025 | CEO Barb Jacobsmeyer announced her intention to step down in July 2026, initiating a search for her successor. |
Enhabit is focusing on expanding its home health census and increasing its hospice average daily census. The company plans to open approximately 10 new sites annually, with a strategic emphasis on hospice locations.
For full-year 2025, Enhabit projects net service revenue between $1.05 billion and $1.08 billion, with adjusted EBITDA anticipated between $101 million and $107 million. The company has also secured new agreements with key payers.
Enhabit is leveraging technology, including AI, to improve back-office functions and enhance care delivery. These efforts are aimed at boosting efficiency and clinical capacity across its operations.
The company is navigating industry shifts such as consolidation and policy changes, while addressing the growing demand for home-based care. Enhabit's strategic contract management and operational improvements are key to sustaining its market position and aligning with its Mission, Vision & Core Values of Enhabit Home Health & Hospice.
Enhabit Home Health & Hospice Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
- What is Competitive Landscape of Enhabit Home Health & Hospice Company?
- What is Growth Strategy and Future Prospects of Enhabit Home Health & Hospice Company?
- How Does Enhabit Home Health & Hospice Company Work?
- What is Sales and Marketing Strategy of Enhabit Home Health & Hospice Company?
- What are Mission Vision & Core Values of Enhabit Home Health & Hospice Company?
- Who Owns Enhabit Home Health & Hospice Company?
- What is Customer Demographics and Target Market of Enhabit Home Health & Hospice Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.